Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.verified

SIGY

Price:

$2

Market Cap:

$3.21M

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

SIGY

The Current Ratio as of December 2025 (TTM) for Sigyn Therapeutics, Inc. (SIGY) is 0.02

According to Sigyn Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.02. This represents a change of 116.71% compared to the average of 0.01 of the last 4 quarters.

Sigyn Therapeutics, Inc. (SIGY) Historical Current Ratio (quarterly & annually)

How has SIGY Current Ratio performed in the past?

The mean historical Current Ratio of Sigyn Therapeutics, Inc. over the last ten years is 0.33. The current 0.02 Current Ratio has changed 543.26% with respect to the historical average. Over the past ten years (40 quarters), SIGY's Current Ratio was at its highest in in the June 2021 quarter at 2.22. The Current Ratio was at its lowest in in the June 2025 quarter at 0.00.

Quarterly (TTM)
Annual

Average

0.33

Median

0.19

Minimum

0.00

Maximum

1.13

Sigyn Therapeutics, Inc. (SIGY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sigyn Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 494.08%

Maximum Annual Current Ratio = 1.13

Minimum Annual Increase = -93.59%

Minimum Annual Current Ratio = 0.00

Quarterly (TTM)
Annual
YearCurrent RatioChange
20240.00-85.93%
20230.03-4.64%
20220.03-93.59%
20210.54-52.50%
20201.13494.08%
20190.1918.43%
20180.16-12.28%
20170.18-37.32%
20160.29-62.49%
20150.78-25.70%

Sigyn Therapeutics, Inc. (SIGY) Average Current Ratio

How has SIGY Current Ratio performed in the past?

The current Current Ratio of Sigyn Therapeutics, Inc. (SIGY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.02

5-year avg

0.35

10-year avg

0.33

Sigyn Therapeutics, Inc. (SIGY) Current Ratio vs. Peers

How is SIGY’s Current Ratio compared to its peers?

Sigyn Therapeutics, Inc.’s Current Ratio is less than Acrux Limited (1.07), greater than ProtoKinetix, Incorporated (0), greater than AXIM Biotechnologies, Inc. (0.00), less than Zelira Therapeutics Limited (0.11), less than RepliCel Life Sciences Inc. (0.03), less than HAVN Life Sciences Inc. (4.51), less than Therma Bright Inc. (0.20), greater than Pharmadrug Inc. (0.02), less than Core One Labs Inc. (0.81), less than IR-Med Inc. (0.12),

Build a custom stock screener for Sigyn Therapeutics, Inc. (SIGY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigyn Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sigyn Therapeutics, Inc. (SIGY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sigyn Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Sigyn Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Sigyn Therapeutics, Inc. (SIGY)?

What is the highest Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?

What is the 3-year average Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?

What is the 5-year average Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?

How does the current Current Ratio for Sigyn Therapeutics, Inc. (SIGY) compare to its historical average?